Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenues:
Premiums	$ 30,925	$ 24,657	$ 91,983	$ 74,117
Net investment income	550	277	1,398	885
Total revenues	95,428	89,764	275,099	263,963
Operating costs:
Cost of products sold	52,948	54,688	151,019	159,679
Health care costs	29,922	21,499	85,578	63,729
Operating expenses	10,557	9,876	31,185	29,329
Restructuring charges	1,169	11	1,169	507
Loss on assets held for sale	0	0	0	349
Total operating costs	94,596	86,074	268,951	253,593
Operating income	832	3,690	6,148	10,370
Interest expense	752	693	2,200	1,968
Other income	(25)	(22)	(74)	(66)
Income before income tax provision	105	3,019	4,022	8,468
Income tax provision	34	754	1,059	2,147
Net income	71	2,265	2,963	6,321
Net (income) loss attributable to noncontrolling interests	16	(4)	7	(23)
Net income attributable to CVS Health	$ 87	$ 2,261	$ 2,970	$ 6,298
Net income per share attributable to CVS Health:
Basic (in dollars per share)	$ 0.07	$ 1.76	$ 2.36	$ 4.90
Diluted (in dollars per share)	$ 0.07	$ 1.75	$ 2.35	$ 4.88
Weighted average shares outstanding:
Basic (in shares)	1,259	1,287	1,258	1,284
Diluted (in shares)	1,259	1,290	1,262	1,289
Dividends declared per share (in dollars per share)	$ 0.665	$ 0.605	$ 1.995	$ 1.815
Cost, Product and Service [Extensible List]	Products	Products	Products	Products
Products
Revenues:
Revenues	$ 59,674	$ 61,298	$ 169,610	$ 179,984
Services
Revenues:
Revenues	$ 4,279	$ 3,532	$ 12,108	$ 8,977